Patents by Inventor Gordon J. Dow

Gordon J. Dow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TOPICAL COMPOSITIONS AND METHODS FOR TREATING PSORIASIS
    Publication number: 20230355640
    Abstract: Topical pharmaceutical compositions comprise a combination of a corticosteroid a retinoid; and methods for treating psoriasis with same.
    Type: Application
    Filed: May 4, 2023
    Publication date: November 9, 2023
    Inventors: Gordon J. DOW, Radhakrishnan PILLAI, Varsha D. BHATT
  • Topical compositions and methods for treating psoriasis
    Patent number: 11679116
    Abstract: Topical pharmaceutical compositions comprise a combination of a corticosteroid a retinoid; and methods for treating psoriasis with same.
    Type: Grant
    Filed: July 2, 2021
    Date of Patent: June 20, 2023
    Assignee: Bausch Health Ireland Limited
    Inventors: Gordon J. Dow, Radhakrishnan Pillai, Varsha D. Bhatt
  • Topical compositions and methods for treating psoriasis
    Patent number: 11679115
    Abstract: Topical pharmaceutical compositions comprise a combination of a corticosteroid a retinoid; and methods for treating psoriasis with same.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: June 20, 2023
    Assignee: Bausch Health Ireland Limited
    Inventors: Gordon J. Dow, Radhakrishnan Pillai, Varsha D. Bhatt
  • Topical compositions and methods for treating psoriasis
    Patent number: 11648256
    Abstract: Topical pharmaceutical compositions comprise a combination of a corticosteroid a retinoid; and methods for treating psoriasis with same.
    Type: Grant
    Filed: November 23, 2022
    Date of Patent: May 16, 2023
    Assignee: Bausch Health Ireland Limited
    Inventors: Gordon J. Dow, Radhakrishnan Pillai, Varsha D. Bhatt
  • TOPICAL COMPOSITIONS AND METHODS FOR TREATING PSORIASIS
    Publication number: 20230086282
    Abstract: Topical pharmaceutical compositions comprise a combination of a corticosteroid a retinoid; and methods for treating psoriasis with same.
    Type: Application
    Filed: November 23, 2022
    Publication date: March 23, 2023
    Inventors: Gordon J. DOW, Radhakrishnan PILLAI, Varsha D. BHATT
  • TOPICAL PHARMACEUTICAL FORMULATIONS CONTAINING A LOW CONCENTRATION OF BENZOYL PEROXIDE IN SUSPENSION IN WATER AND A WATER-MISCIBLE ORGANIC SOLVENT
    Publication number: 20230047106
    Abstract: An aqueous formulation for topical application to the skin comprising water, a water-miscible organic solvent, and benzoyl peroxide, wherein the concentration of the organic solvent is sufficient to provide a stable suspension of benzoyl peroxide in the aqueous formulation without the inclusion of a surfactant in the formulation, wherein the ratio of concentrations of water and organic solvent in the formulation is sufficient to maintain the benzoyl peroxide in saturated solubility in the formulation following application to the skin, and wherein the concentration of benzoyl peroxide in the formulation is less than 5.0% and at least 1.0% w/w. The formulation may further contain a chemical compound in addition to benzoyl peroxide that is effective in the treatment of acne. The aqueous formulations of the invention are useful in the treatment of acne and acne rosacea.
    Type: Application
    Filed: October 19, 2022
    Publication date: February 16, 2023
    Inventors: Yunik Chang, Gordon J. Dow, Radhakrishnan Pillai
  • Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
    Patent number: 11478498
    Abstract: An aqueous formulation for topical application to the skin comprising water, a water-miscible organic solvent, and benzoyl peroxide, wherein the concentration of the organic solvent is sufficient to provide a stable suspension of benzoyl peroxide in the aqueous formulation without the inclusion of a surfactant in the formulation, wherein the ratio of concentrations of water and organic solvent in the formulation is sufficient to maintain the benzoyl peroxide in saturated solubility in the formulation following application to the skin, and wherein the concentration of benzoyl peroxide in the formulation is less than 5.0% and at least 1.0% w/w. The formulation may further contain a chemical compound in addition to benzoyl peroxide that is effective in the treatment of acne. The aqueous formulations of the invention are useful in the treatment of acne and acne rosacea.
    Type: Grant
    Filed: April 20, 2020
    Date of Patent: October 25, 2022
    Assignee: Dow Pharmaceutical Sciences, Inc.
    Inventors: Yunik Chang, Gordon J. Dow, Radhakrishnan Pillai
  • TOPICAL COMPOSITIONS AND METHODS FOR TREATING PSORIASIS
    Publication number: 20210330681
    Abstract: Topical pharmaceutical compositions comprise a combination of a corticosteroid a retinoid; and methods for treating psoriasis with same.
    Type: Application
    Filed: July 2, 2021
    Publication date: October 28, 2021
    Inventors: Gordon J. DOW, Radhakrishnan PILLAI, Varsha D. BHATT
  • TOPICAL COMPOSITIONS AND METHODS FOR TREATING PSORIASIS
    Publication number: 20210145847
    Abstract: Topical pharmaceutical compositions comprise a combination of a corticosteroid a retinoid; and methods for treating psoriasis with same.
    Type: Application
    Filed: January 21, 2021
    Publication date: May 20, 2021
    Inventors: Gordon J. Dow, Radhakrishnan Pillai, Varsha D. Bhatt
  • TOPICAL PHARMACEUTICAL FORMULATIONS CONTAINING A LOW CONCENTRATION OF BENZOYL PEROXIDE IN SUSPENSION IN WATER AND A WATER-MISCIBLE ORGANIC SOLVENT
    Publication number: 20200276218
    Abstract: An aqueous formulation for topical application to the skin comprising water, a water-miscible organic solvent, and benzoyl peroxide, wherein the concentration of the organic solvent is sufficient to provide a stable suspension of benzoyl peroxide in the aqueous formulation without the inclusion of a surfactant in the formulation, wherein the ratio of concentrations of water and organic solvent in the formulation is sufficient to maintain the benzoyl peroxide in saturated solubility in the formulation following application to the skin, and wherein the concentration of benzoyl peroxide in the formulation is less than 5.0% and at least 1.0% w/w. The formulation may further contain a chemical compound in addition to benzoyl peroxide that is effective in the treatment of acne. The aqueous formulations of the invention are useful in the treatment of acne and acne rosacea.
    Type: Application
    Filed: April 20, 2020
    Publication date: September 3, 2020
    Inventors: Yunik Chang, Gordon J. Dow, Radhakrishnan Pillai
  • Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
    Patent number: 10624918
    Abstract: An aqueous formulation for topical application to the skin comprising water, a water-miscible organic solvent, and benzoyl peroxide, wherein the concentration of the organic solvent is sufficient to provide a stable suspension of benzoyl peroxide in the aqueous formulation without the inclusion of a surfactant in the formulation, wherein the ratio of concentrations of water and organic solvent in the formulation is sufficient to maintain the benzoyl peroxide in saturated solubility in the formulation following application to the skin, and wherein the concentration of benzoyl peroxide in the formulation is less than 5.0% and at least 1.0% w/w. The formulation may further contain a chemical compound in addition to benzoyl peroxide that is effective in the treatment of acne. The aqueous formulations of the invention are useful in the treatment of acne and acne rosacea.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: April 21, 2020
    Assignee: Dow Pharmaceutical Sciences, Inc.
    Inventors: Yunik Chang, Gordon J. Dow, Radhakrishnan Pillai
  • Topical compositions and methods for treating psoriasis
    Patent number: 10426787
    Abstract: Topical pharmaceutical compositions comprise a combination of a corticosteroid and a retinoid; and methods for treating psoriasis with same. In one embodiment, the corticosteroid comprises halobetasol propionate, and the retinoid comprises tazarotene.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: October 1, 2019
    Assignee: Bausch Health US, LLC
    Inventors: Gordon J. Dow, Radhakrishnan Pillai, Varsha D. Bhatt
  • TOPICAL COMPOSITIONS AND METHODS FOR TREATING PSORIASIS
    Publication number: 20190231797
    Abstract: Topical pharmaceutical compositions comprise a combination of a corticosteroid a retinoid; and methods for treating psoriasis with same.
    Type: Application
    Filed: April 8, 2019
    Publication date: August 1, 2019
    Inventors: Gordon J. Dow, Radhakrishnan Pillai, Varsha D. Bhatt
  • TOPICAL PHARMACEUTICAL FORMULATIONS CONTAINING A LOW CONCENTRATION OF BENZOYL PEROXIDE IN SUSPENSION IN WATER AND A WATER-MISCIBLE ORGANIC SOLVENT
    Publication number: 20190125776
    Abstract: An aqueous formulation for topical application to the skin comprising water, a water-miscible organic solvent, and benzoyl peroxide, wherein the concentration of the organic solvent is sufficient to provide a stable suspension of benzoyl peroxide in the aqueous formulation without the inclusion of a surfactant in the formulation, wherein the ratio of concentrations of water and organic solvent in the formulation is sufficient to maintain the benzoyl peroxide in saturated solubility in the formulation following application to the skin, and wherein the concentration of benzoyl peroxide in the formulation is less than 5.0% and at least 1.0% w/w. The formulation may further contain a chemical compound in addition to benzoyl peroxide that is effective in the treatment of acne. The aqueous formulations of the invention are useful in the treatment of acne and acne rosacea.
    Type: Application
    Filed: October 26, 2018
    Publication date: May 2, 2019
    Inventors: Yunik Chang, Gordon J. Dow, Radhakrishnan Pillai
  • Topical compositions and methods for treating psoriasis
    Patent number: 10251895
    Abstract: Topical pharmaceutical compositions comprise a combination of a corticosteroid a retinoid; and methods for treating psoriasis with same.
    Type: Grant
    Filed: June 6, 2016
    Date of Patent: April 9, 2019
    Assignee: Valeant Pharmaceuticals North America
    Inventors: Gordon J. Dow, Radhakrishnan Pillai, Varsha D. Bhatt
  • Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
    Patent number: 10220049
    Abstract: An aqueous formulation for topical application to the skin comprising water, a water-miscible organic solvent, and benzoyl peroxide, wherein the concentration of the organic solvent is sufficient to provide a stable suspension of benzoyl peroxide in the aqueous formulation without the inclusion of a surfactant in the formulation, wherein the ratio of concentrations of water and organic solvent in the formulation is sufficient to maintain the benzoyl peroxide in saturated solubility in the formulation following application to the skin, and wherein the concentration of benzoyl peroxide in the formulation is less than 5.0% and at least 1.0% w/w. The formulation may further contain a chemical compound in addition to benzoyl peroxide that is effective in the treatment of acne. The aqueous formulations of the invention are useful in the treatment of acne and acne rosacea.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: March 5, 2019
    Assignee: Dow Pharmaceutical Sciences, Inc.
    Inventors: Yunik Chang, Gordon J. Dow
  • Kinetin/zeatin topical formulation
    Patent number: 10166235
    Abstract: The solubility of kinetin and/or of zeatin is increased when either or both are combined in a formulation that includes a polyoxyalkylene-n-glycerol dicarboxylate component and a fatty acid component. These two components provide a synergistic increase in the solubility of kinetin and/or zeatin that is greater than that which would be expected based on the solubility of kinetin and zeatin in the individual components.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: January 1, 2019
    Assignee: Dow Pharmaceutical Sciences, Inc.
    Inventors: Pramod P. Sarpotdar, Sarmistha Basu, Varsha D. Bhatt, Yunik Chang, Gordon J. Dow
  • Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
    Patent number: 10137142
    Abstract: An aqueous formulation for topical application to the skin comprising water, a water-miscible organic solvent, and benzoyl peroxide, wherein the concentration of the organic solvent is sufficient to provide a stable suspension of benzoyl peroxide in the aqueous formulation without the inclusion of a surfactant in the formulation, wherein the ratio of concentrations of water and organic solvent in the formulation is sufficient to maintain the benzoyl peroxide in saturated solubility in the formulation following application to the skin, and wherein the concentration of benzoyl peroxide in the formulation is less than 5.0% and at least 1.0% w/w. The formulation may further contain a chemical compound in addition to benzoyl peroxide that is effective in the treatment of acne. The aqueous formulations of the invention are useful in the treatment of acne and acne rosacea.
    Type: Grant
    Filed: October 24, 2016
    Date of Patent: November 27, 2018
    Assignee: Dow Pharmaceutical Sciences, Inc.
    Inventors: Yunik Chang, Gordon J. Dow, Radhakrishnan Pillai
  • KINETIN/ZEATIN TOPICAL FORMULATION
    Publication number: 20180311246
    Abstract: The solubility of kinetin and/or of zeatin is increased when either or both are combined in a formulation that includes a polyoxyalkylene-n-glycerol dicarboxylate component and a fatty acid component. These two components provide a synergistic increase in the solubility of kinetin and/or zeatin that is greater than that which would be expected based on the solubility of kinetin and zeatin in the individual components.
    Type: Application
    Filed: March 26, 2018
    Publication date: November 1, 2018
    Inventors: Pramod P. Sarpotdar, Sarmistha Basu, Varsha D. Bhatt, Yunik Chang, Gordon J. Dow
  • TOPICAL COMPOSITIONS AND METHODS FOR TREATING PSORIASIS
    Publication number: 20180177803
    Abstract: Topical pharmaceutical compositions comprise a combination of a corticosteroid and a retinoid; and methods for treating psoriasis with same. In one embodiment, the corticosteroid comprises halobetasol propionate, and the retinoid comprises tazarotene.
    Type: Application
    Filed: February 23, 2018
    Publication date: June 28, 2018
    Inventors: Gordon J. Dow, Radhakrishnan Pillai, Varsha D. Bhatt